PLOD3 was increased in the advanced TNM stages in both TCGA and CPTAC cohorts (Figures 3(a) and 3(b), P value <0.01), and high expression of PLOD3 indicated relatively worse prognosis in COAD. This evidence concerns the gene PLOD3 and colon adenocarcinoma.